Publication Name	World Journal of Hepatology
Manuscript ID	64950
Country	Italy

Received	2021-02-25 17:16
Peer-Review Started	2021-02-25 17:31
To Make the First Decision
Return for Revision	2021-05-03 00:26
Revised	2021-05-06 13:28
Second Decision	2021-10-08 03:30
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-10-11 01:19
Articles in Press	2021-10-11 01:19
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-09-30 13:20
Typeset the Manuscript	2021-11-19 01:03
Publish the Manuscript Online	2021-11-24 09:54

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Liver involvement in inflammatory bowel disease: What should the clinician know?
Manuscript Source	Invited Manuscript
All Author List	Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo and Maria Rendina
Funding Agency and Grant Number
Corresponding Author	Giuseppe Losurdo, MD, Doctor, Doctor, Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Pzza Giulio Cesare, Bari 70124, Italy. giuseppelos@alice.it
Key Words	Inflammatory bowel disease; Liver; Primary sclerosing cholangitis; Viral hepatitis; Immunosuppression; Non-alcoholic fatty liver disease
Core Tip	In the present article, several aspects of liver involvement of inflammatory bowel disease (IBD) have been highlighted. Co-occurrence of primary sclerosing cholangitis is one of the most well-known comorbidities and deserves more attention by the clinician. Liver damage due to drugs used to cure IBD is also a relevant issue. Finally, some emerging topics such as the spread of liver steatosis or the implications of chronic viral hepatitis have been analyzed.
Publish Date	2021-11-24 09:54
Citation	Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551
URL	https://www.wjgnet.com/1948-5182/full/v13/i11/1534.htm
DOI	https://dx.doi.org/10.4254/wjh.v13.i11.1534

Full Article (PDF)	WJH-13-1534.pdf
Full Article (Word)	WJH-13-1534.docx
Manuscript File	64950_Auto_Edited-Wang LL-Webster J.docx
Answering Reviewers	64950-Answering reviewers.pdf
Audio Core Tip	64950-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	64950-Conflict-of-interest statement.pdf
Copyright License Agreement	64950-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	64950-Language certificate.pdf
Peer-review Report	64950-Peer-review(s).pdf
Scientific Misconduct Check	64950-Bing-Wang LL-2.jpg
Scientific Editor Work List	64950-Scientific editor work list.pdf
CrossCheck Report	64950-CrossCheck report.pdf